TARDBP and amyotrophic lateral sclerosis: Subsequently, TDP-43 was identified as a major component of aggregates in a variety of degenerative neurological conditions including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia (FTLD) (Chen-Plotkin et al, 2010).